INVESTIGATIONS OF CHRONIC HEPATITIS B and C IN HIV-INFECTION

Relevance. Today, there are controversies regarding the influence of hepatitis B and C viruses on the course of HIV infection. Objective assess the course and outcomes of chronic hepatitis B and C in HIV-infected patients, as well as to analyze the causes of death of such patients. Materials a...

Full description

Bibliographic Details
Main Authors: V.D. Moskaliuk, I.V. Rudan
Format: Article
Language:English
Published: Bogomolets National Medical University 2022-09-01
Series:Медична наука України
Subjects:
Online Access:https://msu-journal.com/index.php/journal/article/view/402
_version_ 1797672441292521472
author V.D. Moskaliuk
I.V. Rudan
author_facet V.D. Moskaliuk
I.V. Rudan
author_sort V.D. Moskaliuk
collection DOAJ
description Relevance. Today, there are controversies regarding the influence of hepatitis B and C viruses on the course of HIV infection. Objective assess the course and outcomes of chronic hepatitis B and C in HIV-infected patients, as well as to analyze the causes of death of such patients. Materials and methods. A retrospective pseudorandomized study was conducted with a depth of 5 years. 114 medical records of inpatients (HIV infection in association with hepatitis B and C) were selected. The analysis of the causes of death in patients with HIV infection was carried out based on the study of autopsy materials of 21 patients. Results. It was established that the frequency of CHV exacerbation in III-IV clinical stages of HIV infection is significantly higher, and remission is lower than in I-II stages - (36.8±4.5) versus (7.0±2.4)% and (35.1±4.5) and (7.9±2.5)%, respectively (p<0.001). The frequency of liver cirrhosis was characterized by a clear tendency to increase with the deepening of immunodeficiency. The calculation of the frequency of findings in liver cirrhosis showed that in the I-II clinical stage of HIV infection, this value was equal to 0.17, and in the III-IV stage - 0.33. The relative risk of developing liver cirrhosis in HIV-infected patients was 0.52. Moreover, the probability of a fatal outcome in cirrhosis of the liver in HIV-infected patients in the I-II clinical stage was equal to 0.16, and in the III-IV stage - 0.29, with a relative risk of 0.63. The reduction in the relative risk of a fatal outcome taking into account the stage of HIV infection is 0.32. The average life expectancy of patients from the moment of detection of HIV antibodies was (3.4±0.6) years (from 4 months to 9 years). Such a short average life expectancy of HIV-infected patients was caused by a large number of patients diagnosed for the first time already in the IV clinical stage. In more than half (13 out of 21) the causes of death were AIDS-related diseases (61.9 %). Conclusions. A retrospective pseudorandomized study showed that cirrhosis of the liver in the early stages of HIV infection was registered 2.7 times less often than in patients with HIV infection in the stage of secondary diseases. Exacerbation of chronic hepatitis B and C is significantly more often established in the III-IV clinical stage of concomitant HIV infection. Under the same circumstances, signs of cirrhosis of the liver are more often registered, and fatal outcomes occupy one of the leading places in patients with HIV infection. This indicates the need to revise the tactics of clinical management of this category of patients. In 61.9 % of cases, the causes of death were AIDS-indicative diseases. Tuberculosis turned out to be the leading cause of death (46.1 %) of HIV-infected patients and was mainly in a generalized form. Toxoplasmosis (30.8 %) with damage to the brain and other organs takes the second place in terms of the frequency of fatal AIDS-indicative diseases. Meningoencephalitis of unspecified (probably herpetic) etiology was found in 23.1 % of the deceased. An important place in the structure of fatal outcomes in HIV-infected patients is occupied by the terminal stage of cirrhosis of the liver of mixed etiology - viral and alcoholic (38.1 %).
first_indexed 2024-03-11T21:30:06Z
format Article
id doaj.art-acd4af7a1946412491bc5c03decfb634
institution Directory Open Access Journal
issn 2664-472X
2664-4738
language English
last_indexed 2024-03-11T21:30:06Z
publishDate 2022-09-01
publisher Bogomolets National Medical University
record_format Article
series Медична наука України
spelling doaj.art-acd4af7a1946412491bc5c03decfb6342023-09-27T09:50:39ZengBogomolets National Medical UniversityМедична наука України2664-472X2664-47382022-09-01183293410.32345/2664-4738.3.2022.04402INVESTIGATIONS OF CHRONIC HEPATITIS B and C IN HIV-INFECTIONV.D. Moskaliuk0I.V. Rudan1Bukovynian State Medical University, Chernivtsi, UkraineBukovynian State Medical University, Chernivtsi, UkraineRelevance. Today, there are controversies regarding the influence of hepatitis B and C viruses on the course of HIV infection. Objective assess the course and outcomes of chronic hepatitis B and C in HIV-infected patients, as well as to analyze the causes of death of such patients. Materials and methods. A retrospective pseudorandomized study was conducted with a depth of 5 years. 114 medical records of inpatients (HIV infection in association with hepatitis B and C) were selected. The analysis of the causes of death in patients with HIV infection was carried out based on the study of autopsy materials of 21 patients. Results. It was established that the frequency of CHV exacerbation in III-IV clinical stages of HIV infection is significantly higher, and remission is lower than in I-II stages - (36.8±4.5) versus (7.0±2.4)% and (35.1±4.5) and (7.9±2.5)%, respectively (p<0.001). The frequency of liver cirrhosis was characterized by a clear tendency to increase with the deepening of immunodeficiency. The calculation of the frequency of findings in liver cirrhosis showed that in the I-II clinical stage of HIV infection, this value was equal to 0.17, and in the III-IV stage - 0.33. The relative risk of developing liver cirrhosis in HIV-infected patients was 0.52. Moreover, the probability of a fatal outcome in cirrhosis of the liver in HIV-infected patients in the I-II clinical stage was equal to 0.16, and in the III-IV stage - 0.29, with a relative risk of 0.63. The reduction in the relative risk of a fatal outcome taking into account the stage of HIV infection is 0.32. The average life expectancy of patients from the moment of detection of HIV antibodies was (3.4±0.6) years (from 4 months to 9 years). Such a short average life expectancy of HIV-infected patients was caused by a large number of patients diagnosed for the first time already in the IV clinical stage. In more than half (13 out of 21) the causes of death were AIDS-related diseases (61.9 %). Conclusions. A retrospective pseudorandomized study showed that cirrhosis of the liver in the early stages of HIV infection was registered 2.7 times less often than in patients with HIV infection in the stage of secondary diseases. Exacerbation of chronic hepatitis B and C is significantly more often established in the III-IV clinical stage of concomitant HIV infection. Under the same circumstances, signs of cirrhosis of the liver are more often registered, and fatal outcomes occupy one of the leading places in patients with HIV infection. This indicates the need to revise the tactics of clinical management of this category of patients. In 61.9 % of cases, the causes of death were AIDS-indicative diseases. Tuberculosis turned out to be the leading cause of death (46.1 %) of HIV-infected patients and was mainly in a generalized form. Toxoplasmosis (30.8 %) with damage to the brain and other organs takes the second place in terms of the frequency of fatal AIDS-indicative diseases. Meningoencephalitis of unspecified (probably herpetic) etiology was found in 23.1 % of the deceased. An important place in the structure of fatal outcomes in HIV-infected patients is occupied by the terminal stage of cirrhosis of the liver of mixed etiology - viral and alcoholic (38.1 %).https://msu-journal.com/index.php/journal/article/view/402chronic hepatitis b, chronic hepatitis c, hiv infection, combined infection, features of the course, liver cirrhosis, causes of death
spellingShingle V.D. Moskaliuk
I.V. Rudan
INVESTIGATIONS OF CHRONIC HEPATITIS B and C IN HIV-INFECTION
Медична наука України
chronic hepatitis b, chronic hepatitis c, hiv infection, combined infection, features of the course, liver cirrhosis, causes of death
title INVESTIGATIONS OF CHRONIC HEPATITIS B and C IN HIV-INFECTION
title_full INVESTIGATIONS OF CHRONIC HEPATITIS B and C IN HIV-INFECTION
title_fullStr INVESTIGATIONS OF CHRONIC HEPATITIS B and C IN HIV-INFECTION
title_full_unstemmed INVESTIGATIONS OF CHRONIC HEPATITIS B and C IN HIV-INFECTION
title_short INVESTIGATIONS OF CHRONIC HEPATITIS B and C IN HIV-INFECTION
title_sort investigations of chronic hepatitis b and c in hiv infection
topic chronic hepatitis b, chronic hepatitis c, hiv infection, combined infection, features of the course, liver cirrhosis, causes of death
url https://msu-journal.com/index.php/journal/article/view/402
work_keys_str_mv AT vdmoskaliuk investigationsofchronichepatitisbandcinhivinfection
AT ivrudan investigationsofchronichepatitisbandcinhivinfection